Understanding IMPROVE-IT and the cardinal role of LDL-C lowering in CVD prevention

Eur Heart J. 2014 Aug 7;35(30):1996-2000. doi: 10.1093/eurheartj/ehu228. Epub 2014 Jun 10.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Kommentar

MeSH terms

  • Acute Coronary Syndrome / drug therapy*
  • Anticholesteremic Agents / administration & dosage*
  • Azetidines / therapeutic use*
  • Humans
  • Simvastatin / administration & dosage*

Substances

  • Anticholesteremic Agents
  • Azetidines
  • Simvastatin